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A silk elastin-like protein (SELP) is an artificial compound composing silk fibroin-like 
and elastin-like tandem repeats. The objective of this study is to evaluate the SELP 
effect on the migration, proliferation, and proteins production of L929 mouse fibroblasts. 
Upon culturing with different concentrations of SELP, the cells migration and their 
collagen production significantly enhanced in the SELP concentrations from 10-3 to 10 
µg/ml. However, irrespective of the SELP concentration, no difference in the production 
of fibronectin, basic fibroblast growth factor (bFGF), vascular endothelial growth factor 
(VEGF), and stromal cell-derived factor 1α (SDF-1α) was observed. When the 
migration of mouse peritoneal macrophages by SELP was evaluated, significant 
enhancement of macrophages migration was observed in any concentration. It is 
concluded that the SELP has a potential to promote the migration of fibroblasts and 
macrophages, and the fibroblast collagen production.  
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1. Introduction 
Skin wounds disrupt the normal physiology of skin tissue, when the wound is created, 
the healing mechanism is initiated to re-establish skin continuity. Promotion of healing 
is often accompanied by the utilizing wound dressings [1, 2]. The dressing should give a 
favorable moist environment for wound healing, allow gas permeability, and protect the 
wound from the attack of bacteria. In addition, wound dressings need to be non-toxic 
and non-adherent [3-5]. Current strategies focus on the acceleration of wound repairing 
by systematically designed dressing materials [6]. Some researchers have 
experimentally and clinically demonstrated the materials which can accelerate the 
healing processes at molecular, cellular, and systemic levels [7-10]. 
Typical wound healing consists of three phases: inflammation, proliferation, and 
remodeling. At the inflammation phase, macrophages appear at the wound site.  These 
cells, in addition to aggressively removing necrotic or foreign debris and phagocytizing 
bacteria, initiate two important aspects of healing process–angiogenesis and fibroplasia 
[11-16]. They are mediated by various proteins or cytokines released by activated 
macrophages. At the second proliferation phase, fibroblasts produce various 
components of extracellular matrix including collagen and fibronectin, and then 
generate granulation tissues [17]. At the remodeling phase, fibroblasts produce and 
remodel the extracellular matrix, and decrease in size of the underlying contractile 
connective tissue. In this connection, the fibroblasts migration into the wound, higher 
collagen production, and fibroblasts proliferation play a key role in the acceleration of 
wound healing process [18-21]. However, it should be noted that the fibroblast 
phenotype and collagen arrangement are also important factors to be considered for 
wound healing. The wound dressings to promote wound healing at the molecular level 
is of particular interest.  
Silk elastin-like protein (SELP) is produced by recombinant DNA technology with 
relevant genes of silkworm fibroin and human elastin to generate the peptide repeats of 
silk fibroin (GAGAGS) and elastin-like (GVGVP) units, respectively [22]. SELP shows 
biocompatibility and high elasticity of human elastin combined with the mechanical and 
tensile strength of silk fibroin in the molecular structure which is not present naturally 
in one molecule [23]. At concentrations of 4 wt% or higher, water-soluble SELP at room 
temperature can form a hydrogel at the body temperature [24]. Before application, 
SELP is in a liquid state, but can be solidified to form hydrogel at the body temperature. 
The area applied is automatically covered with the SELP hydrogel, and given in a moist 
wound healing condition without inflammation. This property of self-gelation is useful 
as the material of wound covering. SELP has an unique property to suppress cells 
adhesion without their apoptosis [25]. The biocompatibility of SELP is experimentally 
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confirmed by the intradermal injection to guinea pigs [23]. The medical and 
pharmaceutical applications of SELP to tissue engineering and drug delivery system 
have been investigated. [26-28].  
This study is undertaken to obtain the fundamental knowledge of SELP properties for 
the cell behavior. As one of the representation fibroblast cell lines, L929 cells of mouse 
fibroblasts were incubated at different concentrations of SELP to evaluate the effect of 
SELP concentration on the migration, proliferation, and proteins production of 
fibroblasts. We examine the SELP effect on the migration of macrophages which is one 
of the key cells in the process of wound healing. 
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2. Materials and Methods 
2.1. Materials 
A silk elastin-like protein (SELP) is composed of four silk fibroin-like blocks, seven 
elastin-like blocks, and one modified elastin block containing a lysine (K) substitution 
(MDPVVLQRRDWENPGVTQLNRLAAHPPFASDPMGAGSGAGAGS [ (GVGVP)4 
GKGVP (GVGVP)3 (GAGAGS)4 ]12 (GVGVP)4 GKGVP (GVGVP)3 (GAGAGS)2 
GAGAMDPGRYQDLRSHHHHHH) [22]. The SELP was kindly supplied from Sanyo 
Chemical Co., Ltd., Kyoto, Japan.  
 
2.2. L929 cells culture 
A cell line of mouse fibroblasts (L929) was cultured in Dulbecco’s Modified Eagle’s 
medium (DMEM) (Gibco Lifetechnologies Co., Carlsbad, CA) containing 10 vol% fetal 
bovine serum (FBS) (Gibco Lifetechnologies Co., Carlsbad, CA) and 1.0 wt% penicillin 
and streptomycin（Sigma-Aldrich Co., St. Louis, MO） or that containing 1.0 wt% 
penicillin and streptomycin (FBS-free DMEM) in 5% CO2 and 95% air atmosphere at 
37℃. 
 
2.3. In vitro cell migration assay  
In vitro cell migration as a wound healing assay was carried out according to the 
method described by Nakao et al. (2008). L929 cells were plated into each well of 
6-well multi-well plates (Corning Inc., NY, USA) with 2 ml of DMEM at a 
concentration of 5×104 cells/well and cultured for 7 days to make cells confluent. Then, 
a portion of cells monolayer was scratched with a sterile 100 ul plastic pipette tip to 
generate a linear wound as shown in Figure 1. The cellular debris was completely 
removed by washing with phosphate-buffered saline solution (pH 7.4, PBS). Then, 
DMEM containing 10-5 – 103 ug/ml SELP (2 ml/well) was added to the well, followed 
by cell incubation for 0, 24, and 72 hr. The photographs of cells were taken on 
phase-contrast microscope (CKX41, Olympus Optical Co., Japan). The rate of the 
scratched area covered by migrated cells was assessed by Image J (National Institutes 
of Health, Bethesda, MD). The migration ratio was quantitated in three random fields 
for each experimental sample. The distance of cells migrated after incubation at the 
SELP concentration of 0 µg/ml is defined as 1.0 to calculate the migration ratio for 
samples. To exclude the effect of cell proliferation, the similar experiment was 
performed at a concentration of 5 ug/ml mitomycin C (Wako Pure Chemical Industries, 
Ltd., Osaka, Japan).  
 
2.4. Cell proliferation assay 
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Cell proliferation was evaluated according to the method reported previously [29]. L929 
cells were plated into each well of 24-well multi-well plates (Corning Inc., NY, USA) 
with 250 µl of DMEM at a concentration of 2×105 cells/well, followed by 6 hr culture 
to allow cells to attach. Then, 250 µl of DMEM containing 2×10-5 – 2×103 µg/ml 
SELP or 5 µg/ml basic fibroblast growth factor (bFGF) was added to the well. After 
culturing for 18 and 66 hr, 40 ul of a tetrazolium-used colorimetric MTT assay 
cell-counting reagent (Nakalai tesque Co., Japan) was added into each well. After 2 hr of 
incubation, the absorbance of each well at 450nm was measured using a UV-microplate 
reader (VERSAmax, Molecular Devices Inc, USA). The number of cells was calculated 
with a standard curve prepared by using the known numbers of cells. The experiment 
was performed independently 3 times for each sample unless otherwise mentioned. 
 
2.5. Analysis of collagen production 
Trypsinized L929 cells were plated into each well of 6-well multi-well plates with 1.0 
ml of DMEM at a concentration of 2×105 cells/well, followed by 6 hr culture to allow 
cells to attach. Then, 1.0 ml of DMEM containing 2×10-5 – 2×103 µg/ml SELP was 
added to the well, and cultured for 3, 5, 7, 9, and 11 days. Then, the total amount of 
collagen produced was measured with a collagen stain kit based on Sirius red / Fast 
green staining (collagen research center Ltd., Japan) according to the manufacturer’s 
protocol. 
 
2.6. Enzyme-linked immunosorbent assay (ELISA) for fibronectin, growth factors, 
and chemokine  
Trypsinized L929 cells were plated into each well of 24-well multi-well plates with 250 
µl of DMEM at a concentration of 2×105 cells/well, followed by 6 hr culture to allow 
cells to attach. Then 250µl of DMEM containing 2×10-5 – 2×103 µg/ml SELP or 10 
µg/ml transforming growth factor-β3 (TGF-β3) was added to the well. After culturing 
for 3 days, the total amount of fibronectin, basic fibroblast growth factor (bFGF), 
vascular endothelial growth factor (VEGF), and stromal cell-derived factor 1α (SDF-1α) 
were measured with a VEGF ELISA kit (R&D systems Inc., USA), bFGF ELISA kit 
(ray biotech Inc., USA), SDS-1α ELISA kit (R&D systems Inc., USA) and fibronectin 
ELISA kit (Biomedical Technologies Inc., USA) according to the manufacturer’s 
protocol.  
 
2.7. Macrophage migration assay  
Peritoneal macrophages were obtained from of C57BL/6 mice (6–9 weeks, SHIMIZU 
Laboratory Supplies Co., Kyoto, Japan) by the conventional peritoneal lavage method 
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[30]. Prior to 4 days, mice were intraperitoneally injected by 4 w/v % thioglycolate 
medium (2 ml). The mice were sacrificed by the extravasation, and then 5 ml of cold 
PBS was injected into the peritoneal cavity. The peritoneal cavity was massaged for 3 
min. And, the peritoneal fluid was collected by syringe aspiration. The cell suspension 
obtained was centrifuged at 1000 × g for 5 min at 4 ℃ and adjusted to 5×106 cells/ ml 
with RPMI-1640 (Wako Pure Chemical Industries, Ltd., Osaka, Japan) containing 
1.0 wt% penicillin-streptomycin.  
The cell migration assay with a boyden chamber was performed for peritoneal 
macrophages by using transwell chambers with a 8-μm pore-sized membrane (Corning 
Inc., NY, USA). The chambers were inserted into each well 24-well multi-well culture 
plates containing 0 and 10-5 – 103 μg/ml of SELP or 10-8 M N-Formyl-Met-Leu-Phe 
(FMLP) in FCS-free RPMI-1640. Macrophages (5 × 105) were placed into the upper 
portion of boyden chamber. The non-migrating cells were removed with a cotton swab 3 
hr later, and cells were fixed in methanol for 15 min and stained with crystal violet. The 
photographs of cells on transwell membranes were taken on the phase-contrast 
microscope. The photographs of cells migration were viewed to assess the number of 
cells migrated across membrane. The viewing was performed independently 3 times for 
each experimental sample. The number of cells migrated after incubation in the absence 
of SELP is defined as 1.0 to evaluate the migration ration of samples. 
 
2.10. Statistical analysis  
Statistical analyses were performed by using Student’s t-test. The P-value less than 0.05 




3.1. Migration and proliferation of L929 cells cultured with SELP 
Figures 1A – 1D show the effect of SELP concentration on the migration of L929 cells. 
The migration of L929 cells enhanced at the SELP concentrations of 10-1 and 10 µg/ml 
to a significant extent compared with that at 0 µg/ml, 24 hr after addition of SELP. The 
similar result was obtained at 72 hr later, but the influence of SELP concentration on the 
cell migration was different from that 24 hr later. The picture of cell migration also 
showed the similar, effect of SELP concentration. The similar experiment was 
performed for cells which had been treated with mitomycin C, which inhibits the DNA 
synthesis and consequently cell proliferation. The same effect of SELP concentration on 
the cells migration was observed (Figure1E). 
Figure 2 shows the effect of SELP concentration on the proliferation of L929 cells. 
bFGF showed an acceleration effect on the cell proliferation. However, the cells 
proliferation was not enhanced by the SELP, irrespective of the concentration. 
 
3.2. SELP induced collagen production in fibroblast cells 
Figure 3 shows the effect of SELP concentration on the collagen production of L929 
cells after incubation at different concentrations of SELP. When culture at the SELP 
concentrations of 10-5, 10-3, 10-1, and 10 µg/ml, the collagen production enhanced 
significantly 7 and 9 days after incubation, compared with that at different 
concentrations. 
 
3.3. Proteins production of L929 cells cultured with SELP 
Figure 4 shows the effect of SELP concentration on the production of key proteins for 
wound healing process. No difference in the production of bFGF, VEGF and SDF-1α 
was observed, irrespective of the concentration of SELP. The level of fibronectin 
production was not changed by the addition of SELP at any concentration. The addition 
of transforming growth factor-β3 (TGF-β3) as a positive control enhanced the 
production of fibronectin. 
 
3.4. Macrophage migration of SELP 
Figure 5 shows the effect of SELP concentration on the migration of macrophages. 
When culture at the SELP concentrations of 10-3, 10-1, and 10 µg/ml or 
N-Formyl-Met-Leu-Phe (FMLP) as a positive control, macrophages migration enhanced 




We have experimentally confirmed that SELP accelerated the wound healing of a 
full-thickness defect with a diabetic mouse and a guinea pig models (under submission). 
In the animal experiments, the promotion of granulation tissue formation was observed. 
The objective of this study is to evaluate the cellular mechanism of granulation 
promotion by in vitro cell culture experiments. Considering the type of cells working at 
the inflammation process, fibroblasts and macrophages were selected. Their migration 
and proliferation was evaluated. It is well known that the collagen production is one of 
the key events in the formation of granulation tissues [31]. In addition, growth factors 
and chemokines of bFGF or VEGF and SDF-1α also play an important role in the 
wound healing [32]. The present study indicates that the SELP enhanced the migration 
of L929 cells and their collagen production at a certain range of concentration. However, 
the cell proliferation and the production of bFGF, VEGF, SDF-1α, and fibronectin 
were not changed in the presence of SELP.  
There are a lot of reports about response of cell to elastin and silk fibroin [33-45]. 
Unlike in all the others, we could show that SELP promote the wound healing by using 
the in vitro cell culture. SELP already has suitable properties for the wound dressing 
(for example, temperature-responsive gelation, high elasticity, and biological 
compatibility). In addition, we could enhance the value of SELP as the material of 
wound dressing, through this paper. 
Macrophages represent one of the most abundant inflammatory cell types during all 
stages of wound healing [46]. At the first phase of inflammation, macrophages are key 
cells, which can control the subsequent processes [47, 48]. Their primary function upon 
recruitment from blood into the damaged area is to clear cellular debris and necrotic 
tissue. And macrophages sense, and combat invading pathogens. A reduced 
macrophages recruitment causes retarded wound healing [49]. In addition, macrophages 
synthesize numerous growth factors contributing to physiological and pathological 
tissue growth [50, 51]. In this study, the macrophages migration was evaluated. It is 
apparent that the macrophages migration was significantly enhanced by the SELP 
(Figure 5).  
Elastin molecule consists of hydrophobic domains with abundant Gly, Val, Ala, and Pro 
residues which often occur in repeats of several amino acids, like Gly-Val-Gly-Val-Pro 
(GVGVP), Gly-Val-Pro-Gly-Val (GVPGV) and Gly-Val-Gly-Val-Ala-Pro (GVGVAP).  
Elastin sequences interact with a variety of cell types to modulate their behavior. 
Insoluble elastin, for example, has been shown to mediate the cell adhesion of 
monocytes, fibroblasts, and tumor cells. Elastin digests and elastin derived peptides 
have also been shown to be chemoattractants for monocytes and fibroblasts [33-36]. 
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Elastin degradation products have also been shown to act on calcium ion channels in 
monocytes, fibrobrasts, and smooth muscle cells [37], and inhibit platelet aggregation 
[38]. 
Several reports on the effect of specific elastin sequence on cell behavior have been 
reported [34, 35, 39]. Both the monomer and the polymer of VPGVG, which is almost 
similar sequences with SELP elastin block, showed no significant effect on the 
proliferation of skin fibroblasts, while both the monomer and the polymer of VGVAPG 
enhanced the cells proliferation and down-regulated the elastin or collagen mRNA 
levels [39]. The research supports this report that SELP had no positive effect on the cell 
proliferation. 
It have also been reported that the monomer and the polymer of the hexapeptide, 
GVGVAP were chemotactic for bovine ligamentum fibroblasts, while the monomer and 
the polymer of the pentapeptide, GVGVP which is contained in SELP, were not 
chemotactic [35]. However, SELP enhanced the migration of L929 cells and 
macrophages (Figures 1 and 5). Ligamentum nuchae fibroblasts are not migrated by the 
hexapeptide [34]. It suggests the possibility that different portions of elastin molecules 
would have an ability to recruit different types of cells. The signaling pathway of elastin 
peptides, including GVGVP and GVGVAP, have been reported. Depending on the cell 
type, various signaling modules are triggered, converging to the activation of the 
extracellular signal-regulated kinase 1/2 (ERK1/2), which appear as crucial actors in 
elastin peptide signaling [40, 41]. ERK1/2 is the main subfamily of mitogen-activated 
protein kinases (MAPKs), which are linked to the cellular migration in a number of 
systems [42]. It is probable that the ERK1/2 pathway is involved with promoted cell 
migration by SELP. However, the detailed mechanisms of events remain unknown. 
Further study is needed to reveal the signaling pathway triggered by SELP. 
Silk fibroin is a structural protein, and is considered to be a suitable material for skeletal 
tissue engineering because of its good oxygen and water-vapor permeabilities and its in 
vivo minimal inflammatory reaction [52]. In addition, researchers have investigated the 
biological effects of silk fibroin as a matrix, and concluded that silk fibroin has positive 
effects on cell adhesion, viability, growth and differentiated functions [43-45]. In this 
study, SELP used as a soluble agent added into the culture medium, and not as a matrix. 
Therefore, the function of SELP evaluated in this study cannot compare directly with 
that previously reported.  
Silk fibroin-like blocks of SELP can be attributed to the formation of an extended 
crystallineβ-sheet structure that is composed of recurrent sequences of Gly, Ala, and 
Ser amino acids, which in most cases begin with repeats of the GAGAGS hexapeptide 
[53, 54]. In addition, GAGAGS hexapeptide have no discernible impact on cell behavior. 
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Silk fibroin-like blocks of SELP reflect a promising material for biomedical applications, 
due to its biocompatibility, biodegradability and mechanical properties.  
The data of SELP-induced cells activation are not always good enough to explain the in 
vivo effect of SELP on the promoted granulation formation. This may be explained by 
the difference in the state of SELP. In the case of in vivo application, the SELP 
concentration is high enough to set a hydrogel automatically. The hydrogel formation 
covers the skin defect, which may affect the acceleration of granulation formation. It is 
possible that the SELP hydrogels can be degraded in the body to release out the 
water-soluble fragments of SELP. We confirmed that SELP hydogel, which contained 
20 wt% of SELP and 80 wt% of moisture, was degraded in PBS, and release 2.3 ± 
0.5 % at 0 hr, and 16.2 ± 0.5 % of SELP at 72 hr. Taken together, it is highly 
conceivable that in vivo the SELP released out of hydrogels acts on the fibroblasts or 
macrophages, resulting in the enhanced granulation. Considering the biological 
functions of SELP in the body, it is practically important to evaluate the effect on the 
cell behavior in both the hydrogel solid and water-soluble forms. This study focusses on 
the biological effects of latter soluble form. It is no doubt that the cellular effect of 
SELP hydrogel should be evaluated in future. In addition, further investigation of other 
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Figure 1: Effect of SELP concentration on the migration of L929 cells. Migration was 
evaluated for 24 (A, B), and 72 hr (C, D) after incubation with SELP. And migration 
was also evaluated for 24 hr with the addition of mitomycin C (E). The migration ratio 
of cells cultured in the absence of SELP is defined as 1.0 to evaluate the migration 
ration of samples. The scale bar is 300µm. ＊, †, p＜0.05; significant between the 
two groups.  
  
Figure 2: Effect of SELP concentration on the proliferation of L929 cells. Cells were 
incubated with different concentrations of SELP, and 5 µg/ml bFGF. The proliferation 
of cells cultured in the absence of SELP is defined as 1.0. ＊, p＜0.05; significant 
between the two groups. 
 
Figure 3: Effect of SELP concentration on the collagen production of L929 cells 3 ( ), 
5 ( ), 7 ( ), 9 ( ), and 11 days ( ) after incubation with different concentrations of 
SELP. Cells were incubated with different concentrations of SELP. The collagen 
production of cells cultured in the absence of SELP is defined as 1.0. ＊, p＜0.05; 
significant between the two groups. 
 
Figure 4: Effect of SELP concentration on the proteins production of L929 cells: bFGF 
(A), VEGF (B), SDF-1α (C), and fibronectin (D). Cells were incubated with different 
concentrations of SELP, and 10 µg/ml TGF-β3. The proteins production of cells 
cultured in the absence of SELP is defined as 1.0. ＊, p＜0.05; significant between the 
two groups. 
 
Figure 5: Effect of SELP concentration on the migration of macrophages. Migration was 
evaluated 6 hr after incubation with SELP and 10-8 M FMLP. The migration number of 
cells cultured in the absence of SELP is defined as 1.0 to evaluate the migration ratio of 
samples. ＊, †, ‡, †‡, p＜0.05; significant between the two groups. 
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